Thalidomide Combined With Azathioprine as Induction and Maintenance Therapy for Azathioprine-Refractory Crohn's Disease Patients

The combination therapy of thalidomide and azathioprine (AZA) offers an alternative in clinical practice for Crohn's disease (CD) patients experiencing a loss of response to AZA monotherapy. However, little is known about the efficacy and safety of this combination therapy for patients with CD....

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Tong, Qiu, Yun, Li, Xiaozhi, Zhuang, Xiaojun, Huang, Shanshan, Li, Manying, Feng, Rui, Chen, Baili, He, Yao, Zeng, Zhirong, Chen, Minhu, Zhang, Shenghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677527/
https://www.ncbi.nlm.nih.gov/pubmed/33240902
http://dx.doi.org/10.3389/fmed.2020.557986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677527/
https://www.ncbi.nlm.nih.gov/pubmed/33240902
http://dx.doi.org/10.3389/fmed.2020.557986

Ejemplares similares